STOCK TITAN

Minerva Surgical to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Minerva Surgical, a woman's health company focused on Abnormal Uterine Bleeding, announced its participation in two upcoming investor conferences. The H.C. Wainwright Global Investment Conference will feature an on-demand presentation available from 7:00 a.m. ET on May 24, 2022. Additionally, the UBS Global Healthcare Conference 2022 will host a live presentation on May 25, 2022, at 7:45 a.m. ET in New York. Audio webcasts and replays can be accessed via the Minerva website. The company develops minimally invasive solutions to address uterine healthcare needs.

Positive
  • None.
Negative
  • None.

SANTA CLARA, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the following investor conferences:

  • H.C. Wainwright Global Investment Conference
    The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7:00 a.m. Eastern Time on Tuesday, May 24, 2022.
  • UBS Global Healthcare Conference 2022
    Presenting on Wednesday, May 25, 2022 at 7:45 a.m. Eastern Time at the Lotte New York Palace Hotel in New York

The audio webcasts and replays of the presentations may be accessed through the “Recent Events” section of Minerva’s website at http://ir.minervasurgical.com.

About Minerva Surgical, Inc.

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

MEDIA CONTACT

Mike Clapper
mike.clapper@minervasurgical.com
804-295-7676

INVESTOR RELATIONS CONTACT

Caroline Corner
investors@minervasurgical.com
415-202-5678

RELATED LINKS

https://www.aubandme.com

https://www.minervasurgical.com

 


FAQ

When will Minerva Surgical present at the H.C. Wainwright Global Investment Conference?

Minerva Surgical will present at the H.C. Wainwright Global Investment Conference on May 24, 2022, starting at 7:00 a.m. ET.

What time is Minerva Surgical's presentation at the UBS Global Healthcare Conference 2022?

The presentation at the UBS Global Healthcare Conference 2022 will take place on May 25, 2022, at 7:45 a.m. ET.

How can I access the webcasts of Minerva Surgical's presentations?

The audio webcasts and replays of Minerva Surgical's presentations can be accessed through the 'Recent Events' section of their website.

What is the focus of Minerva Surgical as a company?

Minerva Surgical specializes in developing minimally invasive solutions for treating Abnormal Uterine Bleeding and addressing uterine healthcare needs.

MINERVA SURGICAL INC NEW

OTC:UTRS

UTRS Rankings

UTRS Latest News

UTRS Stock Data

5.77M
2.65M
0.43%
70.08%
0.42%
Medical Devices
Healthcare
Link
United States of America
Santa Clara